North America Antacids Market

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

Analysis By Dosage Form (Tablet, Liquid, and Others); Drug Class (Proton Pump Inhibitors, H2 Antagonist, and Acid Neutralizers); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)


No. of Pages: 136    |    Report Code: TIPRE00021092    |    Category: Life Sciences

North America Antacids Market
Buy Now

Market Introduction

The class of drugs that neutralize the acid in the stomach are known as antacids. It is used to treat conditions like heartburn, indigestion, acidity and an upset stomach. These drugs are available over the counter and are usually consumed by mouth. They are available in tablets, capsules, liquid and powder form. There are different types of antacid available like aluminium hydroxide, magnesium carbonate, magnesium trisilicate, magnesium hydroxide, calcium carbonate, and sodium bicarbonate.

 


Get more information on this report

North America Antacids Strategic Insights

Strategic insights for the North America Antacids provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/north-america-antacids-market-strategic-framework.webp
Get more information on this report

North America Antacids Report Scope

Report Attribute Details
Market size in 2019 US$ 2,684.67 Million
Market Size by 2027 US$ 3,564.22 Million
Global CAGR (2020 - 2027) 3.7%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Dosage Form
  • Tablet
  • Liquid
By Drug Class
  • Proton Pump Inhibitors
  • H2 Antagonist
  • Acid Neutralizers
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Bayer AG
  • GlaxoSmithKline plc
  • Takeda Pharmaceutical Company Limited
  • Sun Pharmaceutical Industries Ltd
  • Sanofi
  • Boehringer Ingelheim International GmbH
  • Dr. Reddy's Laboratories
  • Pfizer Inc
  • Reckitt Benckiser Group Plc
  • Procter & Gamble
  • Get more information on this report

    North America Antacids Regional Insights

    The geographic scope of the North America Antacids refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/north-america-antacids-market-geography.webp
    Get more information on this report


    Market Overview and Dynamics

    The North America antacids market is expected to reach US$ 3,564.22 million in 2027 from US$ 2,684.67 million in 2019. The market is estimated to grow with a CAGR of 3.7% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as the growing prevalence of gastroesophageal reflux disease (GERD) and the rising rate of incidence of obesity. However, the market is expected experiencing slow growth during the forecast period owing to the lack of awareness regarding gastrointestinal diseases in developing countries.

     

    Key Market Segments

    Based on dosage form, the antacids market is segmented into tablet, liquid, and others. Based on drug class, the antacids market is segmented into proton pump inhibitors, H2 antagonist, and acid neutralizers. Based on distribution channel, the antacids market, is segmented into hospital pharmacy, retail pharmacy, and online pharmacy.

     

    Major Sources and Companies Listed

    Some of the major primary and secondary sources for antacids market included in the report are the National Institute of Diabetes and Digestive and Kidney Diseases (2014), the National Ambulatory Medical Care Survey (2016), National Center for Health Statistics (NCHS), and others.

     

    Reasons to buy the report

    • To understand the North America antacids market landscape and identify market segments that are most likely to guarantee a strong return
    • Stay ahead of the race by comprehending the ever-changing competitive landscape for antacids market
    • Efficiently plan M&A and partnership deals in North America antacids market by identifying market segments with the most promising probable sales
    • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form antacids market
    • Obtain market revenue forecast for market by various segments from 2019 to 2027 in North America region

     

     

    NORTH AMERICA ANTACIDS MARKET SEGMENTATION

     

    By Dosage Form

    • Tablet
    • Liquid
    • Others

     

    By Drug Class

    • Proton Pump Inhibitors
    • H2 Antagonist
    • Acid Neutralizers
      • Magaldrate
      • Sucralfate
      • Others

     

    By Distribution Channel

    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

     

    By Country

    • North America
    • US
    • Canada
    • Mexico

     

    Company Profiles

    • Bayer AG
    • GlaxoSmithKline plc
    • Takeda Pharmaceutical Company Limited
    • Sun Pharmaceutical Industries Ltd
    • Sanofi
    • Boehringer Ingelheim International GmbH
    • Dr. Reddy's Laboratories
    • Pfizer Inc
    • Reckitt Benckiser Group Plc
    • Procter & Gamble
     

    The List of Companies - North America Antacids Market

    1. Bayer AG
    2. GlaxoSmithKline plc
    3. Takeda Pharmaceutical Company Limited
    4. Sun Pharmaceutical Industries Ltd
    5. Sanofi
    6. Boehringer Ingelheim International GmbH
    7. Dr. Reddy's Laboratories
    8. Pfizer Inc
    9. Reckitt Benckiser Group Plc
    10. Procter & Gamble
    Frequently Asked Questions
    How big is the North America Antacids Market?

    The North America Antacids Market is valued at US$ 2,684.67 Million in 2019, it is projected to reach US$ 3,564.22 Million by 2027.

    What is the CAGR for North America Antacids Market by (2020 - 2027)?

    As per our report North America Antacids Market, the market size is valued at US$ 2,684.67 Million in 2019, projecting it to reach US$ 3,564.22 Million by 2027. This translates to a CAGR of approximately 3.7% during the forecast period.

    What segments are covered in this report?

    The North America Antacids Market report typically cover these key segments-

    • Dosage Form (Tablet, Liquid)
    • Drug Class (Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers)
    • Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)

    What is the historic period, base year, and forecast period taken for North America Antacids Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Antacids Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in North America Antacids Market?

    The North America Antacids Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Bayer AG
  • GlaxoSmithKline plc
  • Takeda Pharmaceutical Company Limited
  • Sun Pharmaceutical Industries Ltd
  • Sanofi
  • Boehringer Ingelheim International GmbH
  • Dr. Reddy's Laboratories
  • Pfizer Inc
  • Reckitt Benckiser Group Plc
  • Procter & Gamble
  • Who should buy this report?

    The North America Antacids Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Antacids Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now